Posted on by ScienceFather

Ā Dr. Andrea Mayado | Immunology | Women Researcher Award

 

šŸ‘Øā€šŸ«Professional Profile šŸŒŸ

I am Andrea Mayado Colino, a Spanish researcher with a strong background in pharmacy. I earned my Bachelor’s degree in Pharmacy from the University of Salamanca in 2006, followed by a Master’s degree and Ph.D. at the Complutense University of Madrid in 2011. My doctoral thesis focused on the involvement of interleukin-1 beta in the preconditioning against neurotoxicity caused by 3,4-methylenedioxymethamphetamine (MDMA) in the rat brain. Throughout my Ph.D., I was awarded a 4-year “FormaciĆ³n de Profesorado Universitario (FPU)” fellowship from the Ministry of Education, Culture, and Sport. Currently, I am a member of the Mastocytosis research team and conduct my research at the Cancer Research Center. I completed my second post-doc at the University of Twente (The Netherlands) in 2018, specializing in early detection of Pancreatic Ductal Adenocarcinoma through liquid biopsy. I have actively participated in 18 competitive financing projects and have a prolific scientific production with 41 publications in top-tier international journals in biomedicine and pharmacology. My cumulative Impact Factor exceeds 330 in the last 5 years, and I hold an H index of 19.

šŸŒ Professional Profiles

 

šŸ§ŖGeneral Quality Indicators of Scientific Research

Total Publications: 41, Publications in First Decile: 19, Publications in First Quartile: 12, First Author Publications: 6, Senior Author Publications: 2, Cumulative Impact Factor: 330.956, H Index: 19, Participation in 18 R&D Projects

Current Professional Situation

Employing Entity: Centro de InvestigaciĆ³n BiomĆ©dica en Red: CĆ”ncer, Professional Category: Investigador posdoctoral (Postdoctoral Researcher), Start Date: 06/04/2023, Type of Contract: Permanent Employment Contract, Dedication Regime: Full Time

Previous Positions and Activities

  • Various postdoctoral positions in prestigious research institutions.
  • Research tasks focused on cellular biology, proteomics, hematological oncology, and systemic mastocytosis.

Education

  • Bachelor’s in Pharmacy, University of Salamanca (2006)
  • Ph.D. in Pharmacology and Human Therapeutics, Complutense University of Madrid (2011)

Teaching Experience

  • Practical courses in Immunology and Pharmacology, University of Salamanca.

Other Activities

Membership in the Spanish Network of Mastocytosis (REMA) and the European Competence Network on Mastocytosis. Participation in various research and biomedical information courses. šŸŒ

Scientific or Technological Activities – R&D Projects

Project: Modulation of the immune response in systemic mastocytosis: role of the cell microenvironment and potential association with the clinical evolution of the disease (PI19/01166) Entity: Proyectos de InvestigaciĆ³n en Salud (AES 2019). Modalidad proyectos en salud. Centro de InvestigaciĆ³n del CĆ”ncer City: Salamanca, Castile and LeĆ³n, Spain Principal Investigator: GarcĆ­a-Montero AC Number of Researchers: 5 Type of Participation: Team member Project: Minimally-invasive blood-based diagnostic tools for early detection of pancreatic cancer. DetecciĆ³n de cĆ©lulas circulantes tumorales en muestras de biopsia lĆ­quida como herramienta diagnĆ³stica del adenocarcinoma ductal de pĆ”ncreas GRS 2041/A/19 Entity: Gerencia Regional de Salud. Junta de Castilla y LeĆ³n. City: Salamanca, Castile and LeĆ³n, Spain Principal Investigator: MuƱoz-Bellvis L Number of Researchers: 9 Type of Participation: Team member Start-End Date: 01/01/2020 – 31/12/2020 Project: DiseƱo y validaciĆ³n de un algoritmo genĆ©tico para predecir la transformaciĆ³n maligna de mastocitosis indolentes a formas agresivas y otras hemopatĆ­as malignas. Design and validation of a genetic algorithm to predict malignant transformation from indolent forms to aggressive forms of systemic mastocytosis. Entity: Proyectos de InvestigaciĆ³n en Salud. Instituto de Salud Carlos. Centro de InvestigaciĆ³n del CĆ”ncer. Institute of Health Carlos III. Cancer Research Institute. Type of Participation: Team member Start-End Date: 2016 – 31/12/2018

šŸ“šTop Noted Publication

Infection Exposure Is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result ofĀ Pax5-Inherited Susceptibility

Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM

Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications

Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis

CD 30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis

Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature

Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression

The immunophenotype of mast cells and its utility in the diagnostic work-up of systemic mastocytosis

Frequency and prognostic impact ofĀ KIT and other genetic variants in indolent systemic mastocytosis

Age distribution of multiple functionally relevant subsets of CD4+ T cells in human blood using a standardized and validated 14-color EuroFlow immune monitoring tube
Andrea Mayado | Immunology | Women Researcher Award

You May Also Like